May 18, 2024

‘New paradigm’ moment as mRNA cancer vaccine slashes risk of tumor relapse or death

Pharma giants Merck and Moderna which developed the shot today heralded the results as ‘spectacular’ and a ‘tremendous step forward’. It targets high-risk melanoma.Pharma giants Merck and Moderna which developed the shot today heralded the results as ‘spectacular’ and a ‘tremendous step forward’. It targets high-risk melanoma.Read MoreHealth News | Mail Online

Leave a Reply

Your email address will not be published. Required fields are marked *